US Food and Drug Administration. Information for Healthcare Profes- sionals. Varenicline (marketed as Chantix). Center for Drug Evaluation and Research. 2008. Available at: http://www.fda.gov/Drugs/Drug Safety/PostmarketDrugSafetyInformationforPatientsandProviders/ ucm124818.htm. Accessed October 9, 2008. 673. US Food and Drug Administration. Public Health Advisory. Important Information on Chantix (varenicline). Center for Drug Evaluation and Research. 2008. Available at: http://www.fda.gov/cder/drug/advisory/ varenicline.htm. Accessed October 9, 2008. 674. Honig A, Kuyper AM, Schene AH, et al. Treatment of postmyocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine. Psychosom Med. 2007;69:606 13. 675. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000; 160:2101 7. 676. Taylor CB, Youngblood ME, Catellier D, et al. Effects of antide- pressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry. 2005;62:792 8. 677. Murray CJ, Lopez AD. Global mortality, disability, and the contri- bution of risk factors: Global Burden of Disease Study. Lancet. 1997; 349:1436 42. 678. Moussavi S, Chatterji S, Verdes E, et al. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007;370:851 8. 679. Carney RM, Rich MW, Tevelde A, et al. Major depressive disorder in coronary artery disease. Am J Cardiol. 1987;60:1273 5. 680. Frasure-Smith N, Lesperance F, Talajic M. Depression following myo- cardial infarction. Impact on month survival. JAMA. 1993;270: 1819 25. 681. Rudisch B, Nemeroff CB. Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry. 2003;54:227 40. 682. Schleifer SJ, ari-Hinson MM, Coyle DA, et al. The nature and course of depression following myocardial infarction. Arch Intern Med. 1989; 149:1785 9. 683. Spertus JA, McDonell M, Woodman CL, et al. 